Consumer metabolic-health company developing science-backed products based on proprietary Precision Metabolite™ Technology licensed from Stanford Medicine research
Consumer metabolic-health company developing science-backed products based on proprietary Precision Metabolite™ Technology licensed from Stanford Medicine research. Its first product, NATLEAN, is designed to support appetite regulation and weight maintenance, particularly for people transitioning off GLP-1 medications, by using naturally occurring metabolites and endogenous satiety signals.